File(s) under permanent embargo
Microbes without frontiers: severe haemolytic-uraemic syndrome due to E coli O104:H4
journal contribution
posted on 2023-06-08, 17:16 authored by Sophie Binks, Kate Regan, Jonathan Richenberg, Timothy ChevassutTimothy ChevassutAntibiotic use in infection with Shiga-toxin-producing strains of Escherichia coli (E coli) is thought to increase the risk of developing haemolytic-uraemic syndrome (HUS). One paediatric study concluded that E coli O157:H7-infected patients who had received antibiotic therapy were 17 times more likely to progress to HUS than those who had not. Quinolones are among those incriminated. In vitro experiments suggest toxin induction of 80-fold with ciprofloxacin and E coli O104:H4. We report here the case of a 44-year-old man returning from Hamburg who presented with a 5 day history of bloody diarrhoea which had worsened after starting ciprofloxacin. A severe illness of overlapping HUS and thrombotic thrombocytopaenic purpura (TTP) ensued, with neurological complications requiring ventilation and intensive care admission. Stool sample eventually confirmed E coli O104:H4. Although the patient made a good recovery following treatment with haemofiltration and plasma exchange with fresh frozen plasma (FFP), ciprofloxacin may have exacerbated his clinical course.
History
Publication status
- Published
File Version
- Published version
Journal
BMJ Case ReportsISSN
1757-790XPublisher
BMJ Publishing GroupExternal DOI
Volume
2012Department affiliated with
- Clinical and Experimental Medicine Publications
Research groups affiliated with
- Haematology Research Group Publications
Full text available
- No
Peer reviewed?
- Yes
Legacy Posted Date
2014-05-14First Compliant Deposit (FCD) Date
2014-05-13Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC